Dasatinib CAS 302962-49-8 Sprycel
Wuhan hanweishi Pharmchem Co., Ltd(Hanways chempharm) is a specialized company concentrating on the R&D, production, marketing and technical service of APIs and pharmaceutical intermediates. The leading products range are APIs, Hormones, Peptides, Pharmaceutical Intermediates. Hanways main market covers more than twenties countries and areas, also we built good and long relations with many big pharmaceutical company worldwide.
Details
Dasatinib CAS 302962-49-8
CAS |
302962-49-8 |
MF |
C22H26ClN7O2S |
MW |
488.01 |
EINECS |
801-607-0 |
Appearance |
Pale yellow powder |
Categories |
Inhibitors;Sprycel;Anticancer Immunity;API; Intermediates & Fine Chemicals. |
Uses |
Dasatinib is an oral potent oncogenic kinase inhibitor, which can block signal of cancer cell replication acceleration , in May 2009, the US Food and Drug Administration (FDA) formally approved the sale of dasatinib , It has been clinically used for the treatment of various chronic myeloid leukemia (CML), including treatment of chronic myeloid leukemia which is resistant or intolerant to the treating programs including imatinib mesylate., Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL) and the treatment of patients with solid tumors. |
CAS NO:114915-14-9
CAS NO:160969-03-9
CAS NO:160968-95-6
CAS NO:427-51-0
CAS NO:17183-98-1
CAS NO:2701-50-0
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View